CDH1 and cancer: Because aberrant E-cadherin expression is associated with cancer initiation and progression, its therapeutic regulation via epigenetic mechanisms, such as methylation/demethylation of the promoter gene region or use non-coding transcripts, such as miRNAs and lncRNAs, may provide a promising strategy in the future.